Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
Sep 3, 2026, 00:14

Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases

Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared a post on LinkedIn about a recent article by Nathan W. Watson et al, published in Stroke, adding:

“Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-analysis

Antiphospholipid antibodies (aPL) are associated with an increased risk of thrombosis.

However, individual studies have reported conflicting findings regarding the prevalence of aPL in patients with ischemic stroke and their association with initial or recurrent events.

Seropositivity for any aPL was observed in nearly 1 in 5 patients with ischemic stroke and was associated with a higher likelihood of ischemic stroke at clinical presentation.”

Title: Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis

Authors: Nathan W. Watson, Syed Bukhari, Sina Rashedi, Mariana Pfeferman, Francisco Ujueta, Bassil Bacare, Brittany N. Weber, Mehrdad Zarghami, Yogendra Kanthi, Eric A. Secemsky, Jean M. Connors, Geoffrey D. Barnes, Sacha Uljon, Samuel Z. Goldhaber, Jeffrey I. Weitz, Karen H. Costenbader, Harlan M. Krumholz, Gregory Piazza, Mary Cushman, Christopher D. Anderson, Mitchell S. V. Elkind, Behnood Bikdeli

Leonardo Roever

Other posts featuring Leonardo Roever on Hemostasis Today.